# Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain

> **NCT03952377** · PHASE1,PHASE2 · TERMINATED · sponsor: **SpineThera Australia PTY LTD** · enrollment: 56 (actual)

## Conditions studied

- Lumbar Radiculopathy

## Interventions

- **DRUG:** SX600
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03952377
- **Lead sponsor:** SpineThera Australia PTY LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-04
- **Primary completion:** 2022-02-21
- **Final completion:** 2022-06-21
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** Due to the impact of COVID-19 and associated enrollment difficulties, the study was terminated with a total sample size of 56 randomized patients
- **Last updated:** 2024-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03952377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03952377, "Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03952377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*